[go: up one dir, main page]

WO2003002117A3 - Derives de pyridine carboxy et un sucre amine - Google Patents

Derives de pyridine carboxy et un sucre amine Download PDF

Info

Publication number
WO2003002117A3
WO2003002117A3 PCT/DK2002/000445 DK0200445W WO03002117A3 WO 2003002117 A3 WO2003002117 A3 WO 2003002117A3 DK 0200445 W DK0200445 W DK 0200445W WO 03002117 A3 WO03002117 A3 WO 03002117A3
Authority
WO
WIPO (PCT)
Prior art keywords
complexes
aminosugar
compositions
niaciamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2002/000445
Other languages
English (en)
Other versions
WO2003002117A2 (fr
Inventor
Morten Sloth Weidner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astion Development AS
Original Assignee
Astion Development AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Development AS filed Critical Astion Development AS
Priority to AU2002313458A priority Critical patent/AU2002313458A1/en
Publication of WO2003002117A2 publication Critical patent/WO2003002117A2/fr
Publication of WO2003002117A3 publication Critical patent/WO2003002117A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a trait à des complexes chimiques composés d'un dérivé de pyridine carboxy et d'un sucre aminé ainsi que des compositions pharmaceutiques et des compléments diététiques comprenant de tels complexes. L'invention concerne également l'utilisation de telles compositions ou complexes pour la préparation d'un médicament ou d'un supplément diététique dans l'élimination de l'hypersensibilité et les réactions inflammatoires telles que des troubles dermatologiques ou un procédé de traitement de tels troubles par l'administration de telles compositions et de tels complexes à un mammifère, tel qu'un humain.
PCT/DK2002/000445 2001-06-29 2002-06-28 Derives de pyridine carboxy et un sucre amine Ceased WO2003002117A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002313458A AU2002313458A1 (en) 2001-06-29 2002-06-28 Niaciamide and derivatives in combination with aminosugar

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200101039 2001-06-29
DKPA200101039 2001-06-29
DKPA200101057 2001-07-04
DKPA200101057 2001-07-04

Publications (2)

Publication Number Publication Date
WO2003002117A2 WO2003002117A2 (fr) 2003-01-09
WO2003002117A3 true WO2003002117A3 (fr) 2003-03-20

Family

ID=26069045

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2002/000445 Ceased WO2003002117A2 (fr) 2001-06-29 2002-06-28 Derives de pyridine carboxy et un sucre amine

Country Status (2)

Country Link
AU (1) AU2002313458A1 (fr)
WO (1) WO2003002117A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
WO2005051388A1 (fr) * 2003-11-21 2005-06-09 Novactyl Incorporated Compositions et procedes utiles au traitement de conjonctivites
FR2876798A1 (fr) 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
WO2023008973A1 (fr) * 2021-07-29 2023-02-02 프라비바이오 주식회사 Nouveau dérivé de benzène et son utilisation associée à l'immunosuppression

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652012A1 (fr) * 1989-03-27 1995-05-10 Albert Naito Combinaison de sucres avec des acides aminés et autres composés
GB2286528A (en) * 1994-02-17 1995-08-23 Robert John Woodward Dietary supplement
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
WO2000007607A1 (fr) * 1998-08-04 2000-02-17 Kosbab, John, V. Compositions nutritives et therapeutiques pour le traitement du cancer
WO2001074781A1 (fr) * 2000-03-21 2001-10-11 Astion Development Aps Complexe chimique contenant un derive carboxy de pyridine a substitution et un glucosaminoglycane
US20020068718A1 (en) * 2000-10-03 2002-06-06 Pierce Scott W. Chondroprotective/restorative compositions and methods of use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652012A1 (fr) * 1989-03-27 1995-05-10 Albert Naito Combinaison de sucres avec des acides aminés et autres composés
GB2286528A (en) * 1994-02-17 1995-08-23 Robert John Woodward Dietary supplement
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
WO2000007607A1 (fr) * 1998-08-04 2000-02-17 Kosbab, John, V. Compositions nutritives et therapeutiques pour le traitement du cancer
WO2001074781A1 (fr) * 2000-03-21 2001-10-11 Astion Development Aps Complexe chimique contenant un derive carboxy de pyridine a substitution et un glucosaminoglycane
US20020068718A1 (en) * 2000-10-03 2002-06-06 Pierce Scott W. Chondroprotective/restorative compositions and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GABY A R: "NATURAL TREATMENTS FOR OSTEOARTHRITIS", ALTERNATIVE MEDICINE REVIEW, THORNE RESEARCH INC., SANDPOINT,, US, vol. 4, no. 5, 1999, pages 330 - 341, XP000992206, ISSN: 1089-5159 *
KROEGER H ET AL: "THE INFLUENCE OF NICOTINAMIDE, TRYPTOPHAN, AND METHIONINE UPON GALACTOSAMINE-INDUCED EFFECTS IN THE LIVER", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, EDITIO CANTOR. AULENDORF, DE, vol. 31, no. 6, PART 1, 1981, pages 987 - 993, XP002949715, ISSN: 0004-4172 *

Also Published As

Publication number Publication date
WO2003002117A2 (fr) 2003-01-09
AU2002313458A1 (en) 2003-03-03

Similar Documents

Publication Publication Date Title
AU2002351583A1 (en) Chitosan oligosaccharides and uses thereof
AU2903300A (en) Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing medicament or a dietary supplement for thetreatment or prevention of inflammation, hypersensitivity reactions or pain
AU2004253242B2 (en) Formulations for the treatment of arhritis conditions
EP2123282A3 (fr) Oligosaccharide immunémodulant
WO2003011881A3 (fr) Derives de sucre d'hydromorphone, dihydromorphine et dihydroisomorphine, leurs compositions et leur utilisation dans le traitement ou la prevention de la douleur
WO2003009741A3 (fr) Methodes de traitement d'une inflammation articulaire, des douleurs, et de perte de la mobilite
AU2728900A (en) Multi-purpose acid compositions
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
JPS61280424A (ja) 創傷治癒剤
WO2002028810A3 (fr) Nouveaux retinoides destines au traitement de l'emphyseme
WO2001030802A3 (fr) Traitements therapeutiques pour des deficiences en cellules sanguines
WO2006120681A3 (fr) Compositions et procedes de soin de la peau
DE60002581D1 (de) Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
WO2003002125A3 (fr) Combinaison de sucres amines et cysteine ou de derives de cysteine
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
WO2007064968A3 (fr) Compositions pharmaceutiques stables de 5,10 methylenetetrahydrofolate
WO2003002117A3 (fr) Derives de pyridine carboxy et un sucre amine
WO2002072035A3 (fr) Compositions anti-inflammatoires et procedes d'utilisation
WO2000056295A3 (fr) Preparations administrables par voie orale associant l'hydroxocobalamine a l'acide folique
WO2004033484A3 (fr) Utilisation de derives stables de la glutamine aux fins d'amelioration de l'absorption medicamenteuse
WO2004006887A3 (fr) Compositions et methodes pour le traitement de troubles cutanes
EP0737476A3 (fr) Une composition pharmaceutique à base d'un dérivé de 3-(2H)-furanone pour la prévention et/ou le traitement de la cataracte
WO2003043632A3 (fr) Methode de therapie du cancer
HUP0204209A2 (hu) Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére
US20030105034A1 (en) Pyridine carboxy derivatives and an aminosugar

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2004104630

Country of ref document: RU

Kind code of ref document: A

Ref document number: 2004105928

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP